CN116515164B - 一种贻贝蛋白抗菌水凝胶及其制备方法与应用 - Google Patents
一种贻贝蛋白抗菌水凝胶及其制备方法与应用 Download PDFInfo
- Publication number
- CN116515164B CN116515164B CN202310605656.5A CN202310605656A CN116515164B CN 116515164 B CN116515164 B CN 116515164B CN 202310605656 A CN202310605656 A CN 202310605656A CN 116515164 B CN116515164 B CN 116515164B
- Authority
- CN
- China
- Prior art keywords
- mussel protein
- polyvinyl alcohol
- sodium alginate
- mussel
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000237536 Mytilus edulis Species 0.000 title claims abstract description 68
- 235000020638 mussel Nutrition 0.000 title claims abstract description 68
- 239000000017 hydrogel Substances 0.000 title claims abstract description 66
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 43
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 43
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000000661 sodium alginate Substances 0.000 claims abstract description 49
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 49
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 63
- 239000007864 aqueous solution Substances 0.000 claims description 36
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 27
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 27
- 235000010413 sodium alginate Nutrition 0.000 claims description 27
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 22
- 239000002131 composite material Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000008367 deionised water Substances 0.000 claims description 13
- 229910021641 deionized water Inorganic materials 0.000 claims description 13
- 241000588724 Escherichia coli Species 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 238000010257 thawing Methods 0.000 claims description 7
- 241000191967 Staphylococcus aureus Species 0.000 claims description 6
- 238000007872 degassing Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 230000008014 freezing Effects 0.000 claims description 4
- 238000007710 freezing Methods 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 2
- 238000006136 alcoholysis reaction Methods 0.000 claims description 2
- 108010004563 mussel adhesive protein Proteins 0.000 claims description 2
- 239000003988 mussel adhesive protein Substances 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 238000009210 therapy by ultrasound Methods 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 abstract description 22
- 230000003647 oxidation Effects 0.000 abstract description 6
- 238000007254 oxidation reaction Methods 0.000 abstract description 6
- 230000010261 cell growth Effects 0.000 abstract description 3
- 230000021164 cell adhesion Effects 0.000 abstract description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract 2
- 210000002744 extracellular matrix Anatomy 0.000 abstract 2
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000002900 effect on cell Effects 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 4
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000037314 wound repair Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 206010061126 Escherichia infection Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 206010042618 Surgical procedure repeated Diseases 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 208000020612 escherichia coli infection Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- -1 polysaccharide sodium alginate Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 208000015339 staphylococcus aureus infection Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000003106 tissue adhesive Substances 0.000 description 1
- 229940075469 tissue adhesives Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/36—After-treatment
- C08J9/40—Impregnation
- C08J9/42—Impregnation with macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2201/00—Foams characterised by the foaming process
- C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
- C08J2201/048—Elimination of a frozen liquid phase
- C08J2201/0484—Elimination of a frozen liquid phase the liquid phase being aqueous
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2205/00—Foams characterised by their properties
- C08J2205/02—Foams characterised by their properties the finished foam itself being a gel or a gel being temporarily formed when processing the foamable composition
- C08J2205/022—Hydrogel, i.e. a gel containing an aqueous composition
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2207/00—Foams characterised by their intended use
- C08J2207/10—Medical applications, e.g. biocompatible scaffolds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2329/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal, or ketal radical; Hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Derivatives of such polymer
- C08J2329/02—Homopolymers or copolymers of unsaturated alcohols
- C08J2329/04—Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
- C08J2405/04—Alginic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2489/00—Characterised by the use of proteins; Derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种贻贝蛋白抗菌水凝胶及其制备方法与应用，将聚乙烯醇水溶液和海藻酸钠水溶液按照不同比例混合均匀，经脱气处理，冷冻‑解冻两次转变为复合水凝胶，随后浸泡在贻贝蛋白乙酸溶液中，最后取出放在室温里吹干得到均匀的抗菌水凝胶。本发明制备工艺简单，易操作，制得的贻贝蛋白‑聚乙烯醇‑海藻酸钠抗菌水凝胶不仅能提高水凝胶的细胞黏附和增殖性能，还能增加一定的抗菌性能和抗氧化性能。该水凝胶呈现多孔结构，能够模拟人体皮肤细胞外基质(ECM)的环境，具有优异的生物相容性，对细胞黏附和生长的有促进作用，对人体无害，有作为理想的敷料的潜能。
Description
技术领域
本发明属于医用材料技术领域，涉及一种贻贝蛋白抗菌水凝胶及其制备方法与应用。
背景技术
在日常生活中，人们会不可避免的受到一些皮肤上的创伤，创伤修复成为了皮肤临床医学上难以解决的问题，特别是大面积不规则的伤口，往往愈合速度较慢，机体不能自主愈合，需要借助外部辅助达到修复的目的。伤口敷料是一种可以起到暂时保护伤口、促进愈合的医用材料。水凝胶具有疏松多孔的结构，具备一定抗压强度，能为伤口提供湿润的环境，具有优异的生物相容性，能够促进伤口修复，可以作为伤口敷料，有着极好的应用前景。
聚乙烯醇(PVA)作为一种人工合成高分子材料，合成方便、价格便宜、对人体安全，具有良好的生物相容性。海藻酸钠(SA)是一种从褐海藻中分离得到的天然多糖，可被广泛应用于食品、制药、组织工程等领域，具有极高的安全性。通过反复冻融制得的聚乙烯醇-海藻酸钠水凝胶，不用添加有一定毒害的交联剂，生物相容性较好，但是聚乙烯醇-海藻酸钠水凝胶有较强的亲水性，不利于细胞粘附，使用的广泛性受到限制。
发明内容
发明目的：本发明所要解决的技术问题是针对现有技术的不足，提供一种强粘附性、抗氧化、抗菌的贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶，以改善传统聚乙烯醇水凝胶的组织粘附性和抗菌性。
为了实现上述目的，本发明采取的技术方案如下：
一种贻贝蛋白抗菌水凝胶的制备方法，包括如下步骤：
(1)将聚乙烯醇溶解于去离子水中，获得聚乙烯醇水溶液；将海藻酸钠溶解于去离子水中，获得海藻酸钠水溶液；
(2)将步骤(1)中聚乙烯醇水溶液和海藻酸钠水溶液混合均匀，得到复合水溶液；
(3)将步骤(2)得到的复合水溶液进行脱气处理，冷冻-解冻两次转变为复合水凝胶；
(4)将贻贝蛋白溶解于乙酸溶液中，获得贻贝蛋白乙酸溶液；
(5)将步骤(3)得到的复合水凝胶充分浸泡在步骤(4)贻贝蛋白乙酸溶液中，取出后在室温下吹干即得。
优选地，步骤(1)中，所述的聚乙烯醇为高黏度的可溶性聚乙烯醇，醇解度为99.0％～99.4％，数均分子量为1～2万；在80～100℃下，将聚乙烯醇溶解于去离子水中，得到质量浓度为5～20％的聚乙烯醇水溶液。
优选地，步骤(1)中，所述的海藻酸钠为可溶性海藻酸钠，聚合度80～750；在45～60℃下，将海藻酸钠溶解于去离子水中，获得质量浓度为0.1～2％的海藻酸钠水溶液。
优选地，步骤(2)中，所述聚乙烯醇水溶液和海藻酸钠水溶液混合体积比1～5:1。
优选地，步骤(3)中，所述的脱气处理的方式为采用超声处理30～60min，静置15～30min；所述的冷冻温度为-80～-20℃，所述的解冻温度为20～25℃。
优选地，步骤(4)中，所述的贻贝蛋白为贻贝足丝蛋白，贻贝足丝蛋白为基因工程菌发酵获得的人工合成贻贝粘附蛋白；所述乙酸溶液的体积浓度为2～5％，2～4℃下将贻贝蛋白溶解于乙酸溶液中，得到浓度为2～10mg/mL的贻贝蛋白乙酸溶液，即贻贝蛋白乙酸溶液中贻贝蛋白的浓度为2～10mg/mL。
本发明中，贻贝蛋白(MFP)是一种生物相容性好，粘附性特别强大的原料。贻贝蛋白带正电荷，能与带负电荷的多糖海藻酸钠静电组装，且贻贝蛋白本身也具备良好的抗菌和抗氧化性能，可以广泛应用于组织粘合剂等粘附性材料的研发中。
优选地，步骤(5)中，所述的复合水凝胶在贻贝蛋白乙酸溶液中的浸泡时间至少为6h，取出后在室温下至少吹干24h。
进一步地，上述制备方法制备得到的贻贝蛋白抗菌水凝胶也在本发明的保护范围之中。
更进一步地，本发明还要求保护上述贻贝蛋白抗菌水凝胶在用于制备伤口敷料中的应用。
更进一步地，本发明还要求保护上述贻贝蛋白抗菌水凝胶在用于制备伤口敷料防止大肠杆菌和金黄色葡萄球菌感染的应用。
有益效果：
本发明以微生物发酵制得的贻贝蛋白、聚乙烯醇海藻酸钠为原料，均为生物相容性好的材料，本发明制备过程无需添加毒副作用的试剂，绿色环保，成本低廉，工艺简单，易于操作，在组织工程、医学等领域具有广阔的应用前景。本发明的方法制得的水凝胶含水量大，机械性能好，生物相容性优异，本发明制得的抗菌水凝胶敷料对大肠杆菌和金黄色葡萄球菌均具有优良的抑制作用，能有效防止伤口感染，扩大了其使用范围，能够作为理想的伤口敷料。
附图说明
下面结合附图和具体实施方式对本发明做更进一步的具体说明，本发明的上述和/或其他方面的优点将会变得更加清楚。
图1本发明实施实例1制备的贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶的扫描电镜图片。
图2本发明实施实例1制备的贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶的抗氧化性能。
图3本发明实施实例1制备的贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶的对大肠杆菌(E.coli)和金黄色葡萄球菌(S.aureus)的抗菌效果。
图4本发明实施实例1制备的贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶的对大肠杆菌(E.coli)和金黄色葡萄球菌(S.aureus)的抗菌率。
图5本发明实施实例1制备的贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶的细胞生长情况。
图6本发明实施实例1制备的贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶的细胞存活率。
具体实施方式
根据下述实施例，可以更好地理解本发明。
实施例1贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶的制备。
100℃下，将100g聚乙烯醇溶解于1L去离子水中，获得10％的聚乙烯醇水溶液；60℃下，将15g海藻酸钠溶解于1L去离子水中，获得1.5％的海藻酸钠水溶液；将聚乙烯醇水溶液：海藻酸钠水溶液＝5:1、3:1和1:1的比例混合均匀，获得复合水溶液；将复合水溶液进行超声脱气处理，-80℃冷冻1h后25℃解冻1h，两次循环后转变为聚乙烯醇-海藻酸钠(PVA-SA)水凝胶；4℃下，将40mg贻贝蛋白溶解于10ml的5％乙酸溶液中，获得4mg/mL的贻贝蛋白乙酸溶液；将PVA-SA水凝胶浸泡在贻贝蛋白乙酸溶液12h，随后取出放在室温里吹干36h得到贻贝蛋白-聚乙烯醇-海藻酸钠(PVA-SA-MFP)抗菌水凝胶。图1是实施例1制备的贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶的扫描电镜图片，可以看出：贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶的内部结构是紧密多孔的，可储存营养物与水分，以及为细胞提供了生长和繁殖的空间，是一个良好的皮肤组织工程领域的生物支架。
实施例2贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶的制备。
85℃下，将75g聚乙烯醇溶解于1L去离子水中，获得7.5％的聚乙烯醇水溶液；45℃下，将10g海藻酸钠溶解于1L去离子水中，获得1％的海藻酸钠水溶液；将聚乙烯醇水溶液：海藻酸钠水溶液＝5:1、3:1和1:1的比例混合均匀，获得复合水溶液；将复合水溶液进行超声脱气处理，-40℃冷冻2h后20℃解冻1.5h，两次循环后转变为聚乙烯醇-海藻酸钠水凝胶；4℃下，将20mg贻贝蛋白溶解于10ml的2％乙酸溶液中，获得2mg/mL的贻贝蛋白乙酸溶液；将PVA-SA水凝胶浸泡在贻贝蛋白乙酸溶液10h，随后取出放在室温里吹干40h得到贻贝蛋白-聚乙烯醇-海藻酸钠抗菌水凝胶敷料。
实施例3贻贝蛋白-聚乙烯醇-海藻酸钠(PVA-SA-MFP)水凝胶的抗氧化性能测试。
称取0.40g DPPH溶解于100ml去离子水中，将实施例1制备的不同比例的PVA-SA-MFP水凝胶用均质器打碎，过滤得到澄清液体。将样品溶液(2mL)放入试管中，加入2mL DPPH(0.1mmol/L)无水乙醇溶液。摇匀后，25℃避光反应30分钟，517nm紫外波长扫描。本实施例对制备的水凝胶的抗氧化性能进行考察，其结果如图2所示。可以观察到经过贻贝蛋白溶液浸泡过的水凝胶的抗氧化性能更好，且在聚乙烯醇水溶液：海藻酸钠水溶液＝1:1的比例时，贻贝蛋白溶液浸泡过的水凝胶抗氧化率最高达到79.6％，这些结果充分说明，本发明的水凝胶在抗氧化上表现优异。
实施例4贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶的抗菌性能测试。
称取15克琼脂粉溶解于100毫升LB中，随后放在立式高压蒸汽灭菌锅，参数设置为：121℃灭菌30分钟。随即在超净台中将其趁热倒入细胞培养皿，风干备用。将活化后的大肠杆菌(ATCC 25933)和金黄色葡萄球菌(ATCC 6538)培养液用PBS缓冲液稀释至106CFU/mL。将实施例3中最佳抗氧化性能比例的的贻贝蛋白-聚乙烯醇-海藻酸钠(PVA-SA-MFP)水凝胶与菌液共同培养，放置于37℃恒温培养箱中孵育12小时，吸取100微升稀释的菌液均匀滴在LB培养板中，用涂布棒均匀涂布至菌液完全吸收。观察菌落生长情况，并用相机拍照记录。本实施例对制备的水凝胶的抗菌性能进行考察，其结果如图3所示。可以观察到，经过贻贝蛋白溶液浸泡过的水凝胶，接触部位更加透明，细菌生长较少，抗菌效果更好。结合图4中水凝胶对大肠杆菌和金黄葡萄球菌的抗菌率更充分说明了本发明的水凝胶在抗菌上表现优异。
实施例5贻贝蛋白-聚乙烯醇-海藻酸钠水凝胶的生物相容性测试。
利用噻唑蓝(MTT)法检测实施例3中最佳抗氧化性能比例的的贻贝蛋白-聚乙烯醇-海藻酸钠(PVA-SA-MFP)水凝胶对L929小鼠成纤维细胞的细胞毒性。将水凝胶浸泡在基础细胞培养基中，在4℃冰箱中保存1、2和3天。在96孔板中每孔接种细胞，并置于37℃恒温培养箱中孵育36小时，吸出孔中的培养基，将其替换水凝胶预处理的培养基，以未经任何处理的DMEM培养基作为对照组。在37℃培养箱中分别孵育24和48小时后，吸出培养基，用PBS缓冲液轻轻冲洗每个孔，该步骤重复三次。向孔中加入0.2毫升MTT的DMEM溶液(0.5毫克/毫升)，37℃恒温培养箱中孵育4小时。轻轻吸出培养基，向孔中加入0.2毫升二甲基亚砜以溶解蓝紫色结晶甲臜。15分钟后用荧光倒置显微镜拍照记录，其结果如图5所示。该结果表明了复合水凝胶处理下的小鼠细胞72h的生长状况，复合水凝胶对小鼠成纤维细胞几乎没有任何毒性作用，并且结合图6的水凝胶的细胞存活率进一步说明对细胞生长有一定促进作用。
本发明提供了一种贻贝蛋白抗菌水凝胶及其制备方法与应用的思路及方法，具体实现该技术方案的方法和途径很多，以上所述仅是本发明的优选实施方式，应当指出，对于本技术领域的普通技术人员来说，在不脱离本发明原理的前提下，还可以做出若干改进和润饰，这些改进和润饰也应视为本发明的保护范围。本实施例中未明确的各组成部分均可用现有技术加以实现。
Claims (7)
1.一种贻贝蛋白抗菌水凝胶的制备方法，其特征在于，包括如下步骤：
（1）将聚乙烯醇溶解于去离子水中，获得聚乙烯醇水溶液；将海藻酸钠溶解于去离子水中，获得海藻酸钠水溶液；
（2）将步骤（1）中聚乙烯醇水溶液和海藻酸钠水溶液混合均匀，得到复合水溶液；
（3）将步骤（2）得到的复合水溶液进行脱气处理，冷冻-解冻两次转变为复合水凝胶；
（4）将贻贝蛋白溶解于乙酸溶液中，获得贻贝蛋白乙酸溶液；
（5）将步骤（3）得到的复合水凝胶充分浸泡在步骤（4）贻贝蛋白乙酸溶液中，取出后在室温下吹干即得；
所述的聚乙烯醇为高黏度的可溶性聚乙烯醇，醇解度为99.0%～99.4 %，数均分子量为1~2万；在80~100℃下，将聚乙烯醇溶解于去离子水中，得到质量浓度为5~20%的聚乙烯醇水溶液；
所述的海藻酸钠为可溶性海藻酸钠，聚合度80~750；在45~60℃下，将海藻酸钠溶解于去离子水中，获得质量浓度为0.1~2%的海藻酸钠水溶液；
所述的贻贝蛋白为贻贝足丝蛋白，贻贝足丝蛋白为基因工程菌发酵获得的人工合成贻贝粘附蛋白；所述乙酸溶液的体积浓度为2~5%，2~4℃下将贻贝蛋白溶解于乙酸溶液中，得到浓度为2~10mg/mL的贻贝蛋白乙酸溶液。
2.根据权利要求1所述的贻贝蛋白抗菌水凝胶的制备方法，其特征在于，步骤（2）中，所述聚乙烯醇水溶液和海藻酸钠水溶液混合体积比1~5:1。
3.根据权利要求1所述的贻贝蛋白抗菌水凝胶的制备方法，其特征在于，步骤（3）中，所述的脱气处理的方式为采用超声处理30~60min，静置15~30min；所述的冷冻温度为-80~-20℃，所述的解冻温度为20~25℃。
4.根据权利要求1所述的贻贝蛋白抗菌水凝胶的制备方法，其特征在于，步骤（5）中，所述的复合水凝胶在贻贝蛋白乙酸溶液中的浸泡时间至少为6h，取出后在室温下至少吹干24h。
5.权利要求1~4中任意一项所述制备方法制备得到的贻贝蛋白抗菌水凝胶。
6.权利要求5所述的贻贝蛋白抗菌水凝胶在用于制备伤口敷料中的应用。
7.根据权利要求5所述的贻贝蛋白抗菌水凝胶在用于制备伤口敷料防止大肠杆菌和金黄色葡萄球菌感染的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310605656.5A CN116515164B (zh) | 2023-05-26 | 2023-05-26 | 一种贻贝蛋白抗菌水凝胶及其制备方法与应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310605656.5A CN116515164B (zh) | 2023-05-26 | 2023-05-26 | 一种贻贝蛋白抗菌水凝胶及其制备方法与应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116515164A CN116515164A (zh) | 2023-08-01 |
| CN116515164B true CN116515164B (zh) | 2024-03-19 |
Family
ID=87406460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310605656.5A Active CN116515164B (zh) | 2023-05-26 | 2023-05-26 | 一种贻贝蛋白抗菌水凝胶及其制备方法与应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116515164B (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100118860A (ko) * | 2009-04-29 | 2010-11-08 | 한남대학교 산학협력단 | 생체적합성 폴리비닐알콜계 하이드로겔의 제조방법 |
| CN105477674A (zh) * | 2014-10-10 | 2016-04-13 | 北京铂铱电气科技有限公司 | 一种基于壳聚糖与海洋贻贝粘蛋白的止血复合材料及其制备方法 |
| WO2018093161A1 (ko) * | 2016-11-16 | 2018-05-24 | 포항공과대학교 산학협력단 | 홍합 접착 단백질을 포함하는 신규한 지혈제 및 이의 제조 방법 |
| CN109354886A (zh) * | 2018-11-07 | 2019-02-19 | 中国科学院烟台海岸带研究所 | 复合水凝胶及其制备方法 |
| CN109942905A (zh) * | 2019-03-01 | 2019-06-28 | 昆明理工大学 | 一种复合水凝胶材料及其制备方法 |
-
2023
- 2023-05-26 CN CN202310605656.5A patent/CN116515164B/zh active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100118860A (ko) * | 2009-04-29 | 2010-11-08 | 한남대학교 산학협력단 | 생체적합성 폴리비닐알콜계 하이드로겔의 제조방법 |
| CN105477674A (zh) * | 2014-10-10 | 2016-04-13 | 北京铂铱电气科技有限公司 | 一种基于壳聚糖与海洋贻贝粘蛋白的止血复合材料及其制备方法 |
| WO2018093161A1 (ko) * | 2016-11-16 | 2018-05-24 | 포항공과대학교 산학협력단 | 홍합 접착 단백질을 포함하는 신규한 지혈제 및 이의 제조 방법 |
| CN109354886A (zh) * | 2018-11-07 | 2019-02-19 | 中国科学院烟台海岸带研究所 | 复合水凝胶及其制备方法 |
| CN109942905A (zh) * | 2019-03-01 | 2019-06-28 | 昆明理工大学 | 一种复合水凝胶材料及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116515164A (zh) | 2023-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111662464B (zh) | 一种壳聚糖/海藻酸钠双网络水凝胶的制备方法 | |
| CN110354295B (zh) | 一种光热转换材料及其制备方法 | |
| CN112300420B (zh) | 一种可注射抗菌互穿双网络水凝胶及其制备方法和应用 | |
| WO2023231050A1 (zh) | 一种强韧抗菌水凝胶敷料及其制备方法 | |
| CN110237782B (zh) | 一种高强度抗氧化壳聚糖/聚多巴胺复合水凝胶的制备方法 | |
| CN109851844B (zh) | 一种原位接枝改性抗菌海藻酸钙海绵的制备方法及应用 | |
| CN112876694B (zh) | 丙烯酸/ε-聚赖氨酸黏附性抗菌水凝胶的制备方法及其应用 | |
| CN111558081A (zh) | 一种单宁酸改性双层水凝胶及其制备方法 | |
| CN116650710A (zh) | 一种贻贝启发的多功能双网络交联水凝胶伤口敷料 | |
| CN113788871A (zh) | 一种配位化合物及其制备方法和应用 | |
| CN106344954A (zh) | 一种生物抗菌细菌纤维素敷料及其制备方法 | |
| CN110152055B (zh) | 海藻酸胺化衍生物/细菌纤维素纳米晶复合凝胶构筑的功能性药物缓释医用敷料 | |
| CN105944135B (zh) | 一种复合海绵及其制备方法 | |
| CN116515164B (zh) | 一种贻贝蛋白抗菌水凝胶及其制备方法与应用 | |
| Wei et al. | Enzymatic one-pot preparation of carboxylmethyl chitosan-based hydrogel with inherent antioxidant and antibacterial properties for accelerating wound healing | |
| CN113509591A (zh) | 一种抗菌阳离子可注射水凝胶敷料及其制备方法 | |
| CN112870431A (zh) | 具有g-四链体结构用作级联反应器的抗菌水凝胶及其制备方法及应用 | |
| CN111184906B (zh) | 一种基于pva的液体敷料及其制备方法 | |
| CN114479124B (zh) | 一种可自愈水凝胶、其制备方法及应用 | |
| CN113214508B (zh) | 一种用于皮肤修复的天然抗菌凝胶及其制备方法 | |
| CN107469133A (zh) | 新型功能敷料 | |
| CN115010958A (zh) | 一种用于促进伤口愈合的水凝胶及其制备方法和应用 | |
| CN112190754A (zh) | 一种用于治疗伤口缺损的水凝胶敷料及其制备方法和应用 | |
| Zhou et al. | Preparation of chitin-lysozyme anti-infective eco-friendly dressing and its effect on wound healing | |
| CN118324937A (zh) | 一种多糖基水凝胶及其制备方法、应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |